FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Limited)

View source ↗

Summary

FDA approved Dr. Reddy's Laboratories' supplemental application for clopidogrel bisulfate, approving changes to the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Ischemic Heart Disease
• Myocardial Infarction
• Peripheral Artery Disease
• Stroke
• Transient Ischemic Attack

Drugs mentioned

• Clopidogrel bisulfate (clopidogrel bisulfate)

Snippet

SUPPL AP for CLOPIDOGREL BISULFATE (CLOPIDOGREL BISULFATE)